{"title":"Vital residues-orientated rational design of butenolide inhibitors targeting Of ChtI","authors":"Qing Han, Yun-Jiang Zi, Tian-Yu Feng, Nan Wu, Ren-Xuan Zou, Jing-Yu Zhang, Ru-Lei Zhang, Qing Yang, Hong-Xia Duan","doi":"10.1007/s00044-024-03211-5","DOIUrl":null,"url":null,"abstract":"<div><p>An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues (<b>Ia-f</b> and <b>IIa-f</b>) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds <b>IIa-f</b> (R<sup>2</sup> = NO<sub>2</sub>) exhibited slightly higher inhibitory potency against <i>Of</i> ChtI compared to compounds <b>Ia-f</b> (R<sup>2</sup> = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO<sub>2</sub> group and Trp107, explaining the enhanced binding affinities. Compounds <b>IIe</b> and <b>IIf</b>, both bearing NO<sub>2</sub> on the benzene ring at the R<sup>2</sup> position, displayed the highest inhibitory activity, with <i>K</i><sub>i</sub> values of 0.87 and 0.68 <i>μ</i>M, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of <i>Of</i> ChtI.</p></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"33 5","pages":"740 - 747"},"PeriodicalIF":2.6000,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-024-03211-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
An effective approach for discovering small molecular inhibitors is the residues-oriented strategy based on enzyme analysis. In this study, we employed a rational approach to design and synthesize a library of butenolide analogues (Ia-f and IIa-f) targeting Trp107, utilizing reported piperonyl butenolide as lead compound. Notably, the most compounds IIa-f (R2 = NO2) exhibited slightly higher inhibitory potency against Of ChtI compared to compounds Ia-f (R2 = Br). Molecular mechanism studies unveiled a crucial hydrogen bond interaction between the NO2 group and Trp107, explaining the enhanced binding affinities. Compounds IIe and IIf, both bearing NO2 on the benzene ring at the R2 position, displayed the highest inhibitory activity, with Ki values of 0.87 and 0.68 μM, respectively. Our findings highlight the potential of designing inhibitors with high enzymatic activity by structurally optimizing compounds based on the distinct interaction modes with crucial residues in the binding cavity of Of ChtI.
期刊介绍:
Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.